PT509398E - Quinoxalinas processo para a sua preparacao e sua utilizacao - Google Patents

Quinoxalinas processo para a sua preparacao e sua utilizacao Download PDF

Info

Publication number
PT509398E
PT509398E PT92106158T PT92106158T PT509398E PT 509398 E PT509398 E PT 509398E PT 92106158 T PT92106158 T PT 92106158T PT 92106158 T PT92106158 T PT 92106158T PT 509398 E PT509398 E PT 509398E
Authority
PT
Portugal
Prior art keywords
alkyl
alkoxy
chloro
amino
alkylamino
Prior art date
Application number
PT92106158T
Other languages
English (en)
Portuguese (pt)
Inventor
Billhardt Dr Uta-Maria
Rosner Dr Manfred
Riess Dr Gunther
Irvin Winkler
Bender Dr Rudolf
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19914142322 external-priority patent/DE4142322A1/de
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT509398E publication Critical patent/PT509398E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
PT92106158T 1991-04-15 1992-04-09 Quinoxalinas processo para a sua preparacao e sua utilizacao PT509398E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4112234 1991-04-15
DE19914142322 DE4142322A1 (de) 1991-12-20 1991-12-20 Chinoxaline, verfahren zu ihrer herstellung und ihreverwendung

Publications (1)

Publication Number Publication Date
PT509398E true PT509398E (pt) 2002-02-28

Family

ID=25902841

Family Applications (1)

Application Number Title Priority Date Filing Date
PT92106158T PT509398E (pt) 1991-04-15 1992-04-09 Quinoxalinas processo para a sua preparacao e sua utilizacao

Country Status (18)

Country Link
EP (1) EP0509398B1 (en, 2012)
JP (1) JP2718595B2 (en, 2012)
KR (1) KR100245138B1 (en, 2012)
AT (1) ATE205837T1 (en, 2012)
AU (1) AU654178B2 (en, 2012)
CA (1) CA2065985A1 (en, 2012)
CZ (1) CZ293825B6 (en, 2012)
DE (1) DE59209965D1 (en, 2012)
DK (1) DK0509398T3 (en, 2012)
ES (1) ES2164639T3 (en, 2012)
HU (1) HU224439B1 (en, 2012)
IE (1) IE921187A1 (en, 2012)
IL (1) IL101583A (en, 2012)
MX (1) MX9201760A (en, 2012)
NZ (1) NZ242346A (en, 2012)
PT (1) PT509398E (en, 2012)
TW (1) TW207533B (en, 2012)
ZA (1) ZA922722B (en, 2012)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE201677T1 (de) * 1992-04-23 2001-06-15 Merrell Pharma Inc 4-imidomethyl-1-(2'-phenyl-2-oxoethyl)-piperidi e als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendung
TW304945B (en, 2012) * 1992-06-27 1997-05-11 Hoechst Ag
TW274550B (en, 2012) * 1992-09-26 1996-04-21 Hoechst Ag
DE4335438A1 (de) * 1993-10-18 1995-04-20 Bayer Ag 4-Cyanophenyliminoheterocyclen
DE4342024A1 (de) * 1993-12-09 1995-06-14 Hoechst Ag Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid
DE4344452A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4437406A1 (de) * 1994-10-19 1996-04-25 Hoechst Ag Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19506742A1 (de) * 1995-02-27 1996-08-29 Bayer Ag Verwendung von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
DE19613591A1 (de) * 1996-04-04 1997-10-09 Hoechst Ag Substituierte-Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19703131A1 (de) * 1997-01-29 1998-07-30 Bayer Ag Verwendung von Chinoxalin in Dreier-Kombination mit Protease-Inhibitoren und Reverse Transkriptaseinhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
FR2760237B1 (fr) * 1997-02-28 1999-04-16 Rhone Poulenc Rorer Sa Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
US6288075B1 (en) 1998-02-26 2001-09-11 Rhone-Poulenc Rorer S.A. Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same
AU1881900A (en) 1998-12-23 2000-07-31 Aventis Pharma Limited Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
DE10134721A1 (de) * 2001-07-17 2003-02-06 Bayer Ag Tetrahydrochinoxaline
WO2005018531A2 (en) * 2003-08-26 2005-03-03 'chemical Diversity Research Institute', Ltd. Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
JP5054996B2 (ja) * 2006-03-14 2012-10-24 参天製薬株式会社 グルココルチコイド受容体結合活性を有する新規1,2,3,4−テトラヒドロキノキサリン誘導体
ES2396711T3 (es) 2006-03-14 2013-02-25 Santen Pharmaceutical Co., Ltd Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene actividad de unión al receptor de glucocorticoides
JP5183302B2 (ja) 2007-05-29 2013-04-17 参天製薬株式会社 グルココルチコイド受容体結合活性を有する、スルホン酸エステル又はスルホン酸アミド構造を導入したフェニル基を置換基として有する新規1,2,3,4−テトラヒドロキノキサリン誘導体
CN103242238B (zh) * 2013-05-10 2016-04-20 常州齐晖药业有限公司 一种芬苯达唑的制备方法
WO2015007730A1 (en) 2013-07-15 2015-01-22 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death
CA2920353A1 (en) 2013-08-09 2015-02-12 Santen Pharmaceutical Co., Ltd. Production method for ,3-dimethyl-3,4-dihydro-1h-quinoxaline-2-one derivative and intermediate for said production method
WO2016075137A1 (en) 2014-11-10 2016-05-19 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE706623A (en, 2012) * 1967-11-16 1968-04-01
US4032639A (en) * 1976-03-22 1977-06-28 American Home Products Corporation 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and derivatives thereof for relieving hypertension
EP0190105A3 (de) * 1985-01-31 1988-10-26 Ciba-Geigy Ag Herbizides Mittel
WO1992005160A1 (en) * 1986-10-30 1992-04-02 Reinhard Sarges 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts
US5318946A (en) * 1991-11-27 1994-06-07 American Cyanamid Company 2-(heteroaryloxyphenoxy)alkylsulfonates useful as herbicidal agents

Also Published As

Publication number Publication date
AU1485392A (en) 1992-10-22
CZ113692A3 (en) 1993-01-13
MX9201760A (es) 1992-10-01
ES2164639T3 (es) 2002-03-01
CA2065985A1 (en) 1992-10-16
HU9201288D0 (en) 1992-07-28
HK1011971A1 (en) 1999-07-23
IL101583A0 (en) 1992-12-30
IL101583A (en) 2000-07-16
DE59209965D1 (de) 2002-10-17
JP2718595B2 (ja) 1998-02-25
EP0509398A1 (de) 1992-10-21
HU224439B1 (hu) 2005-09-28
HUT61004A (en) 1992-11-30
KR920019761A (ko) 1992-11-19
EP0509398B1 (de) 2001-09-19
ATE205837T1 (de) 2001-10-15
TW207533B (en, 2012) 1993-06-11
CZ293825B6 (cs) 2004-08-18
JPH05148243A (ja) 1993-06-15
NZ242346A (en) 1994-12-22
AU654178B2 (en) 1994-10-27
ZA922722B (en) 1992-11-25
DK0509398T3 (da) 2002-01-14
KR100245138B1 (ko) 2000-03-02
IE921187A1 (en) 1992-10-21

Similar Documents

Publication Publication Date Title
PT509398E (pt) Quinoxalinas processo para a sua preparacao e sua utilizacao
KR100226114B1 (ko) 항증식 작용을 가진 퀴나졸린 화합물
DE60218037T2 (de) Neue indolderivate mit affinität zum 5-ht6-rezeptor
CN106220635B (zh) 作为parp抑制剂的稠合的四环或五环的二氢二氮杂*并咔唑酮
ES2358048T3 (es) Nuevas isotiazoloquinolonas y compuestos relacionados como agentes antiinfecciosos.
JPH06211855A (ja) アザキノキサリン類、それらの製造方法およびそれらの使用
TW201524959A (zh) Kras g12c之抑制劑
CN103153996A (zh) 作为激酶抑制剂的喹啉和喹喔啉衍生物
HUE029370T2 (hu) Rákellenes aktivitású vegyületek
TW200817405A (en) Pyrro[1,2-b]pyridazinone compounds
IE83508B1 (en) Quinoxalines, processes for their preparation, and their use
US6369057B1 (en) Quinoxalines, processes for their preparation and their use
TW200916458A (en) Heterocyclic compounds and methods of use thereof
JPWO2009041559A1 (ja) インダゾールアクリル酸アミド化合物
NZ270088A (en) Antiviral medicaments containing a quinoxaline and a nucleoside derivative
CZ20032677A3 (cs) Derivát fenylheterocyklyletheru jako inhibitor reabsorpce serotoninu, jeho použití a farmaceutický prostředek, který ho obsahuje
HUT71680A (en) Process for producing lactam dipeptides having hle inhibiting activity
WO2022171088A1 (zh) 吡唑并[3,4-d]嘧啶-3-酮衍生物
TW200920362A (en) Alkylsulfone derivatives
EP1156047B1 (en) 6-substituted-7- heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both
Patel et al. Synthesis and antimicrobial screening of some new pyrazoline and 1, 6-dihydropyrimidine derivatives
JP2001048865A (ja) 経鼻剤
HK1011971B (en) Quinoxalines, process for their preparation and their use
JP2000191641A (ja) アミノグアニジンヒドラゾン誘導体、その製法及び剤
HK1122024A1 (en) 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents